Observational studyChinese medical journal2026

Benefit of oxaliplatin-based chemotherapy or capecitabine monotherapy in older patients with stage III and high-risk stage II colon cancer: Data from the National Colorectal Cancer Cohort study in China.

Fei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.